Assuming resistance is required, the following results were found.

  • New technology to monitor anti-drug antibodies in MS patients may have potential for COVID-19 testing

    to monitor the presence of anti-drug antibodies in the treatment of multiple sclerosis (MS), which can lead to drug resistance and treatment failure. The researchers say that they have also applied the technology to COVID-19 for potential use in...

    https://mschristian.org/index.php/new-technology-to-monitor-anti-drug-antibodies-in-ms-patients-may-have-potential-for-covid-19-testing
  • #ECTRIMS2019 - Are Injectables Inappropriate for Active Relapsing MS? - Multiple Sclerosis News Today

    injectables, offer benefits in several clinical outcomes, namely annual relapse rates, disability progression, treatment resistance, and health-related quality of life. With more high-efficacy therapies becoming available, is it now inappropriate to...

    https://mschristian.org/index.php/blog/ectrims2019-are-injectables-inappropriate-for-active-relapsing-ms-multiple-sclerosis-news-today
  • Assessment and Measurement of Spasticity in MS: State of the Evidence.

    worsens and impacting activity, participation, and quality of life. Spasticity manifests in many ways, including spasms, resistance to passive stretch, pain, and perception of tightness, and can affect muscles throughout the body, making assessment and...

    https://mschristian.org/index.php/blog/assessment-and-measurement-of-spasticity-in-ms-state-of-the-evidence
  • #ECTRIMS2019 - Are Injectables Inappropriate for Active Relapsing MS? - Multiple Sclerosis News Today

    injectables, offer benefits in several clinical outcomes, namely annual relapse rates, disability progression, treatment resistance, and health-related quality of life. Use from the start Early intervention is key. “We really have a window of...

    https://mschristian.org/index.php/articles/2-uncategorised/8956-ectrims2019-are-injectables-inappropriate-for-active-relapsing-ms-multiple-sclerosis-news-today
  • Johns Hopkins researchers identify new way to lower blood pressure in obese patients

    rising levels of the molecule after a meal no longer boost metabolism or cause a feeling of fullness. In response to this resistance, leptin levels continue to rise with obesity. Leptin has also been shown to increase blood pressure and, surprisingly,...

    https://mschristian.org/index.php/articles/2-uncategorised/8727-johns-hopkins-researchers-identify-new-way-to-lower-blood-pressure-in-obese-patients
  • Aubagio (teriflunomide)

    oxidation, and N-acetylation. Aubagio is a CYP1A2 inducer and inhibits CYP2C8, efflux transporter breastcancer resistance protein (BCRP), OATP1B1, and OAT3. Aubagio has a half-life of 18 to 19 days and is primarily excreted through feces (approximately...

    https://mschristian.org/index.php/articles/2-uncategorised/8433-aubagio-teriflunomide
  • What are the best exercises for MS?

    the body from overheating, which can worsen MS symptoms. Also, the feeling of weightlessness combined with the subtle resistance of the water creates an excellent environment for low-impact exercising. Beyond swimming, people can perform various types...

    https://mschristian.org/index.php/articles/2-uncategorised/7910-what-are-the-best-exercises-for-ms
  • Johns Hopkins researchers identify new way to lower blood pressure in obese patients

    rising levels of the molecule after a meal no longer boost metabolism or cause a feeling of fullness. In response to this resistance, leptin levels continue to rise with obesity. Leptin has also been shown to increase blood pressure and, surprisingly,...

    https://mschristian.org/index.php/blog/johns-hopkins-researchers-identify-new-way-to-lower-blood-pressure-in-obese-patients
  • What are the best exercises for MS?

    the body from overheating, which can worsen MS symptoms. Also, the feeling of weightlessness combined with the subtle resistance of the water creates an excellent environment for low-impact exercising. Beyond swimming, people can perform various types...

    https://mschristian.org/index.php/blog/what-are-the-best-exercises-for-ms
  • Aubagio (teriflunomide)

    oxidation, and N-acetylation. Aubagio is a CYP1A2 inducer and inhibits CYP2C8, efflux transporter breast cancer resistance protein (BCRP), OATP1B1, and OAT3. Aubagio has a half-life of 18 to 19 days and is primarily excreted through feces (approximately...

    https://mschristian.org/index.php/blog/aubagio-teriflunomide

Results 1 - 10 of 10